Pulmonary aspiration : New therapeutic approaches in the experimental model
Acute lung injury caused by gastric aspiration is a frequent occurrence in unconscious patients. Acute respiratory distress syndrome in association with gastric aspiration carries a mortality of up to 30% and accounts for up to 20% of deaths associated with anesthesia. Although the clinical conditio...
Gespeichert in:
Veröffentlicht in: | Anesthesiology (Philadelphia) 2005-09, Vol.103 (3), p.556-566 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 566 |
---|---|
container_issue | 3 |
container_start_page | 556 |
container_title | Anesthesiology (Philadelphia) |
container_volume | 103 |
creator | BECK-SCHIMMER, Beatrice ROSENBERGER, Dorothea S SCHIMMER, Ralph C NEFF, Simona B JAMNICKI, Marina SUTER, Dominik FUHRER, Thomas SCHWENDENER, Reto BOOY, Christa REYES, Livia PASCH, Thomas |
description | Acute lung injury caused by gastric aspiration is a frequent occurrence in unconscious patients. Acute respiratory distress syndrome in association with gastric aspiration carries a mortality of up to 30% and accounts for up to 20% of deaths associated with anesthesia. Although the clinical condition is well known, knowledge about the exact inflammatory mechanisms is still incomplete. This study was performed to define the role of alveolar macrophages in this inflammatory response. In addition, potentially modifying effects of intratracheally applied nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate were investigated.
Rat alveolar macrophages were depleted by intratracheal administration of clodronate liposomes, and lung injury was evaluated 6 h after instillation of 0.1N hydrochloric acid. In a second set of experiments, pyrrolidine dithiocarbamate was intratracheally instilled 3 h after hydrochloric acid application, and injury parameters were determined.
Depletion of alveolar macrophages resulted in decreased production of inflammatory mediators in acid aspiration (23-80% reduction of messenger RNA or protein of inflammatory mediators; P < 0.05) and consequently also in diminished neutrophil recruitment (36% fewer neutrophils; P < 0.01). Treatment with pyrrolidine dithiocarbamate was highly effective in decreasing neutrophil recruitment (66%; P < 0.01) and vascular permeability (80%; P < 0.001).
These data suggest that alveolar macrophages play an essential role in the inflammatory response of acid-induced lung injury. For the first time, attenuation of acid-induced lung injury with an inhibitor, applied after the onset of injury, is shown. |
doi_str_mv | 10.1097/00000542-200509000-00019 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68525850</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68525850</sourcerecordid><originalsourceid>FETCH-LOGICAL-p239t-b65d86e6e4cc86f60b4750768652807553b056933b19fd726983613787eaea4c3</originalsourceid><addsrcrecordid>eNpFj1tLxDAQhYMo7rr6FyQv-hbNpbn5Jos3XNQHfS5pOmUjvdm0qP_eLFYcGA5n5mM4gxBm9IJRqy_prmTGCU9CbTIkNbN7aMkkN4QxLffRMs0EEZTzBTqK8T1ZLYU5RAumGLfWsCV6fJnqpmvd8I1d7MPgxtC1-Ao_wScetzC4HqYxeOz6fuic30LEod1tMHz1MIQG2tHVuOlKqI_RQeXqCCezrtDb7c3r-p5snu8e1tcb0nNhR1IoWRoFCjLvjaoULTItqVZGpegpoRQFlcoKUTBblZora4RiQhsNDlzmxQqd_95NkT4miGPehOihrl0L3RRzZSSXRtIEns7gVDRQ5n3Kmz7N_95PwNkMuOhdXQ2u9SH-c5pljAklfgA2IGmr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68525850</pqid></control><display><type>article</type><title>Pulmonary aspiration : New therapeutic approaches in the experimental model</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>BECK-SCHIMMER, Beatrice ; ROSENBERGER, Dorothea S ; SCHIMMER, Ralph C ; NEFF, Simona B ; JAMNICKI, Marina ; SUTER, Dominik ; FUHRER, Thomas ; SCHWENDENER, Reto ; BOOY, Christa ; REYES, Livia ; PASCH, Thomas</creator><creatorcontrib>BECK-SCHIMMER, Beatrice ; ROSENBERGER, Dorothea S ; SCHIMMER, Ralph C ; NEFF, Simona B ; JAMNICKI, Marina ; SUTER, Dominik ; FUHRER, Thomas ; SCHWENDENER, Reto ; BOOY, Christa ; REYES, Livia ; PASCH, Thomas</creatorcontrib><description>Acute lung injury caused by gastric aspiration is a frequent occurrence in unconscious patients. Acute respiratory distress syndrome in association with gastric aspiration carries a mortality of up to 30% and accounts for up to 20% of deaths associated with anesthesia. Although the clinical condition is well known, knowledge about the exact inflammatory mechanisms is still incomplete. This study was performed to define the role of alveolar macrophages in this inflammatory response. In addition, potentially modifying effects of intratracheally applied nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate were investigated.
Rat alveolar macrophages were depleted by intratracheal administration of clodronate liposomes, and lung injury was evaluated 6 h after instillation of 0.1N hydrochloric acid. In a second set of experiments, pyrrolidine dithiocarbamate was intratracheally instilled 3 h after hydrochloric acid application, and injury parameters were determined.
Depletion of alveolar macrophages resulted in decreased production of inflammatory mediators in acid aspiration (23-80% reduction of messenger RNA or protein of inflammatory mediators; P < 0.05) and consequently also in diminished neutrophil recruitment (36% fewer neutrophils; P < 0.01). Treatment with pyrrolidine dithiocarbamate was highly effective in decreasing neutrophil recruitment (66%; P < 0.01) and vascular permeability (80%; P < 0.001).
These data suggest that alveolar macrophages play an essential role in the inflammatory response of acid-induced lung injury. For the first time, attenuation of acid-induced lung injury with an inhibitor, applied after the onset of injury, is shown.</description><identifier>ISSN: 0003-3022</identifier><identifier>EISSN: 1528-1175</identifier><identifier>DOI: 10.1097/00000542-200509000-00019</identifier><identifier>PMID: 16129981</identifier><identifier>CODEN: ANESAV</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Anesthesia ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Biological and medical sciences ; Bronchoalveolar Lavage Fluid - chemistry ; Capillary Permeability ; Chemokine CCL2 - physiology ; Disease Models, Animal ; Inflammation Mediators - physiology ; Macrophages, Alveolar - physiology ; Male ; Medical sciences ; NF-kappa B - antagonists & inhibitors ; Pneumonia, Aspiration - drug therapy ; Pneumonia, Aspiration - etiology ; Pyrrolidines - therapeutic use ; Rats ; Rats, Wistar ; Respiratory Distress Syndrome, Adult - etiology ; Thiocarbamates - therapeutic use ; Tumor Necrosis Factor-alpha - biosynthesis</subject><ispartof>Anesthesiology (Philadelphia), 2005-09, Vol.103 (3), p.556-566</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17141136$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16129981$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BECK-SCHIMMER, Beatrice</creatorcontrib><creatorcontrib>ROSENBERGER, Dorothea S</creatorcontrib><creatorcontrib>SCHIMMER, Ralph C</creatorcontrib><creatorcontrib>NEFF, Simona B</creatorcontrib><creatorcontrib>JAMNICKI, Marina</creatorcontrib><creatorcontrib>SUTER, Dominik</creatorcontrib><creatorcontrib>FUHRER, Thomas</creatorcontrib><creatorcontrib>SCHWENDENER, Reto</creatorcontrib><creatorcontrib>BOOY, Christa</creatorcontrib><creatorcontrib>REYES, Livia</creatorcontrib><creatorcontrib>PASCH, Thomas</creatorcontrib><title>Pulmonary aspiration : New therapeutic approaches in the experimental model</title><title>Anesthesiology (Philadelphia)</title><addtitle>Anesthesiology</addtitle><description>Acute lung injury caused by gastric aspiration is a frequent occurrence in unconscious patients. Acute respiratory distress syndrome in association with gastric aspiration carries a mortality of up to 30% and accounts for up to 20% of deaths associated with anesthesia. Although the clinical condition is well known, knowledge about the exact inflammatory mechanisms is still incomplete. This study was performed to define the role of alveolar macrophages in this inflammatory response. In addition, potentially modifying effects of intratracheally applied nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate were investigated.
Rat alveolar macrophages were depleted by intratracheal administration of clodronate liposomes, and lung injury was evaluated 6 h after instillation of 0.1N hydrochloric acid. In a second set of experiments, pyrrolidine dithiocarbamate was intratracheally instilled 3 h after hydrochloric acid application, and injury parameters were determined.
Depletion of alveolar macrophages resulted in decreased production of inflammatory mediators in acid aspiration (23-80% reduction of messenger RNA or protein of inflammatory mediators; P < 0.05) and consequently also in diminished neutrophil recruitment (36% fewer neutrophils; P < 0.01). Treatment with pyrrolidine dithiocarbamate was highly effective in decreasing neutrophil recruitment (66%; P < 0.01) and vascular permeability (80%; P < 0.001).
These data suggest that alveolar macrophages play an essential role in the inflammatory response of acid-induced lung injury. For the first time, attenuation of acid-induced lung injury with an inhibitor, applied after the onset of injury, is shown.</description><subject>Anesthesia</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bronchoalveolar Lavage Fluid - chemistry</subject><subject>Capillary Permeability</subject><subject>Chemokine CCL2 - physiology</subject><subject>Disease Models, Animal</subject><subject>Inflammation Mediators - physiology</subject><subject>Macrophages, Alveolar - physiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>NF-kappa B - antagonists & inhibitors</subject><subject>Pneumonia, Aspiration - drug therapy</subject><subject>Pneumonia, Aspiration - etiology</subject><subject>Pyrrolidines - therapeutic use</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Respiratory Distress Syndrome, Adult - etiology</subject><subject>Thiocarbamates - therapeutic use</subject><subject>Tumor Necrosis Factor-alpha - biosynthesis</subject><issn>0003-3022</issn><issn>1528-1175</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFj1tLxDAQhYMo7rr6FyQv-hbNpbn5Jos3XNQHfS5pOmUjvdm0qP_eLFYcGA5n5mM4gxBm9IJRqy_prmTGCU9CbTIkNbN7aMkkN4QxLffRMs0EEZTzBTqK8T1ZLYU5RAumGLfWsCV6fJnqpmvd8I1d7MPgxtC1-Ao_wScetzC4HqYxeOz6fuic30LEod1tMHz1MIQG2tHVuOlKqI_RQeXqCCezrtDb7c3r-p5snu8e1tcb0nNhR1IoWRoFCjLvjaoULTItqVZGpegpoRQFlcoKUTBblZora4RiQhsNDlzmxQqd_95NkT4miGPehOihrl0L3RRzZSSXRtIEns7gVDRQ5n3Kmz7N_95PwNkMuOhdXQ2u9SH-c5pljAklfgA2IGmr</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>BECK-SCHIMMER, Beatrice</creator><creator>ROSENBERGER, Dorothea S</creator><creator>SCHIMMER, Ralph C</creator><creator>NEFF, Simona B</creator><creator>JAMNICKI, Marina</creator><creator>SUTER, Dominik</creator><creator>FUHRER, Thomas</creator><creator>SCHWENDENER, Reto</creator><creator>BOOY, Christa</creator><creator>REYES, Livia</creator><creator>PASCH, Thomas</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20050901</creationdate><title>Pulmonary aspiration : New therapeutic approaches in the experimental model</title><author>BECK-SCHIMMER, Beatrice ; ROSENBERGER, Dorothea S ; SCHIMMER, Ralph C ; NEFF, Simona B ; JAMNICKI, Marina ; SUTER, Dominik ; FUHRER, Thomas ; SCHWENDENER, Reto ; BOOY, Christa ; REYES, Livia ; PASCH, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p239t-b65d86e6e4cc86f60b4750768652807553b056933b19fd726983613787eaea4c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Anesthesia</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bronchoalveolar Lavage Fluid - chemistry</topic><topic>Capillary Permeability</topic><topic>Chemokine CCL2 - physiology</topic><topic>Disease Models, Animal</topic><topic>Inflammation Mediators - physiology</topic><topic>Macrophages, Alveolar - physiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>NF-kappa B - antagonists & inhibitors</topic><topic>Pneumonia, Aspiration - drug therapy</topic><topic>Pneumonia, Aspiration - etiology</topic><topic>Pyrrolidines - therapeutic use</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Respiratory Distress Syndrome, Adult - etiology</topic><topic>Thiocarbamates - therapeutic use</topic><topic>Tumor Necrosis Factor-alpha - biosynthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BECK-SCHIMMER, Beatrice</creatorcontrib><creatorcontrib>ROSENBERGER, Dorothea S</creatorcontrib><creatorcontrib>SCHIMMER, Ralph C</creatorcontrib><creatorcontrib>NEFF, Simona B</creatorcontrib><creatorcontrib>JAMNICKI, Marina</creatorcontrib><creatorcontrib>SUTER, Dominik</creatorcontrib><creatorcontrib>FUHRER, Thomas</creatorcontrib><creatorcontrib>SCHWENDENER, Reto</creatorcontrib><creatorcontrib>BOOY, Christa</creatorcontrib><creatorcontrib>REYES, Livia</creatorcontrib><creatorcontrib>PASCH, Thomas</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Anesthesiology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BECK-SCHIMMER, Beatrice</au><au>ROSENBERGER, Dorothea S</au><au>SCHIMMER, Ralph C</au><au>NEFF, Simona B</au><au>JAMNICKI, Marina</au><au>SUTER, Dominik</au><au>FUHRER, Thomas</au><au>SCHWENDENER, Reto</au><au>BOOY, Christa</au><au>REYES, Livia</au><au>PASCH, Thomas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pulmonary aspiration : New therapeutic approaches in the experimental model</atitle><jtitle>Anesthesiology (Philadelphia)</jtitle><addtitle>Anesthesiology</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>103</volume><issue>3</issue><spage>556</spage><epage>566</epage><pages>556-566</pages><issn>0003-3022</issn><eissn>1528-1175</eissn><coden>ANESAV</coden><abstract>Acute lung injury caused by gastric aspiration is a frequent occurrence in unconscious patients. Acute respiratory distress syndrome in association with gastric aspiration carries a mortality of up to 30% and accounts for up to 20% of deaths associated with anesthesia. Although the clinical condition is well known, knowledge about the exact inflammatory mechanisms is still incomplete. This study was performed to define the role of alveolar macrophages in this inflammatory response. In addition, potentially modifying effects of intratracheally applied nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate were investigated.
Rat alveolar macrophages were depleted by intratracheal administration of clodronate liposomes, and lung injury was evaluated 6 h after instillation of 0.1N hydrochloric acid. In a second set of experiments, pyrrolidine dithiocarbamate was intratracheally instilled 3 h after hydrochloric acid application, and injury parameters were determined.
Depletion of alveolar macrophages resulted in decreased production of inflammatory mediators in acid aspiration (23-80% reduction of messenger RNA or protein of inflammatory mediators; P < 0.05) and consequently also in diminished neutrophil recruitment (36% fewer neutrophils; P < 0.01). Treatment with pyrrolidine dithiocarbamate was highly effective in decreasing neutrophil recruitment (66%; P < 0.01) and vascular permeability (80%; P < 0.001).
These data suggest that alveolar macrophages play an essential role in the inflammatory response of acid-induced lung injury. For the first time, attenuation of acid-induced lung injury with an inhibitor, applied after the onset of injury, is shown.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>16129981</pmid><doi>10.1097/00000542-200509000-00019</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-3022 |
ispartof | Anesthesiology (Philadelphia), 2005-09, Vol.103 (3), p.556-566 |
issn | 0003-3022 1528-1175 |
language | eng |
recordid | cdi_proquest_miscellaneous_68525850 |
source | MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals |
subjects | Anesthesia Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Animals Biological and medical sciences Bronchoalveolar Lavage Fluid - chemistry Capillary Permeability Chemokine CCL2 - physiology Disease Models, Animal Inflammation Mediators - physiology Macrophages, Alveolar - physiology Male Medical sciences NF-kappa B - antagonists & inhibitors Pneumonia, Aspiration - drug therapy Pneumonia, Aspiration - etiology Pyrrolidines - therapeutic use Rats Rats, Wistar Respiratory Distress Syndrome, Adult - etiology Thiocarbamates - therapeutic use Tumor Necrosis Factor-alpha - biosynthesis |
title | Pulmonary aspiration : New therapeutic approaches in the experimental model |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A11%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pulmonary%20aspiration%20:%20New%20therapeutic%20approaches%20in%20the%20experimental%20model&rft.jtitle=Anesthesiology%20(Philadelphia)&rft.au=BECK-SCHIMMER,%20Beatrice&rft.date=2005-09-01&rft.volume=103&rft.issue=3&rft.spage=556&rft.epage=566&rft.pages=556-566&rft.issn=0003-3022&rft.eissn=1528-1175&rft.coden=ANESAV&rft_id=info:doi/10.1097/00000542-200509000-00019&rft_dat=%3Cproquest_pubme%3E68525850%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68525850&rft_id=info:pmid/16129981&rfr_iscdi=true |